UK VCs Refused Meetings When Fred Turner Was 18
Fred Turner · We Built Our Own Salesforce in Months. Here's Why We're Cancelling the $600K Contract | Curative CEO · Jul 18, 2026 · at 2:17
Fred Turner, founder and CEO of Curative, describes his experience trying to raise venture capital in the UK as an 18-year-old college student before relocating to Silicon Valley.
0:00 / 0:16exact quote · 16.8s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
0:00 / 0:58
The StarZero cut
A short vertical edit of this exact moment, cut and captioned from the tape above. The tape stays the evidence; this is the version you can send someone.
Save the cut (mp4) →“Like when I found, I tried to raise a venture around in the UK and I couldn't even get meetings. This was when I was like, I was 18. I was in like first year of college and I was doing this startup on the side. I couldn't even get meetings with, I think I got like one fund to take an associate meeting with me.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Fred Turner
Curative Canceled $600K Salesforce Contract For An Internally Vibe-Coded CRM
“We just recently canceled our Salesforce contract because we have an internal CRM that was vibe coded, that is working better, that is managing our process better, is more integrated into what we're doing. We run our agents inside of it, and no one was using S…”
Curative Is Cutting 80% Of Its Enterprise SaaS Spend This Year
“We're cutting about 80% of our SaaS spend this year.”
Corporate Anthropic Spend Will Reach 2x To 5x Engineer Salaries
“Between maybe two and five X would be the two and five X salary.”
Curative Headcount Will Shrink In Short Term Due To AI
“We're about 650 people now. In five years we'll probably be bigger. In the short term I think we're going to be quite a bit smaller.”
Strategic Investor Pulling Series B Term Sheet Caused Shield's Collapse
“Ended up getting a term sheet from a strategic, large public diagnostic company. Signed the term sheet, did three weeks of work on docs. We were in the second round of docs, and then their CEO killed it because it was too competitive with their core products. …”